Abstract
In June 1972, the Frederick Cancer Research Center (FCRC) began operations under contract arrangements with the U.S. National Cancer Institute (NCI). Since then the Center has grown to its present size, diversity, and importance. In 1973, the Chemotherapy Fermentation Laboratory (CFL), which was to include an intermediate scale production unit or pilot plant, was first proposed for installation at FCRC as a service operation in support of the Division of Cancer Treatment (DCT) of the NCI.
Program sponsored by NCI under contract #NO1-CO-25423 with Litton Bionetics, Inc.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Arcamone, F., Cassinelli, G., Fantini, G., Grein, A., Orezzi, P., Pol, C., Spalla, G.: Adriamycin, 14-hydroxydaunomycin, A new antitumor antibiotic from S. peucetius var. caesius. Biotechnol. Bioeng. 11, 1101–1110 (1969).
Arcamone, F., Cassinelli, G., diMarco, A., Gaetani, M.: Adriamycin Derivatives. U.S. Pat. 3,590,028 (June 29, 1971).
Aszalos, A. A., Bachur, N. R., Hamilton, B. K., Langlykke, A. F., Roller, P. P., Sheikh, M. Y., Sutphin, M. S.: Thomas, M. C., Wareheim, D. A., Wright, L. H.: Microbial reduction of the side-chain carbonyl of daunorubicin and N-acetyldaunorubicin. J. Antibiot. (Tokyo) 30, 50–58 (1977).
Blair, H. E.: Personal communication (1977).
Fuska, J., Proska, B.: Cytotoxic and antitumor antibiotics produced by microorganisms. Adv. Appl. Microbiol. 20, 259–370 (1976).
Gitterman, C. O., Rickes, E. L., Wolf, D. E., Madas, J., Zimmerman, S. B., Stoudt, T. H., Demny, T. C.: The human tumor-egg host system IV. Discovery of a new antitumor agent, Compound 593A. J. Antibiot. (Tokyo) 23, 305–310 (1970).
Humphrey, A. E., Aiba, S., Millis, N. F.: Biochemical Engineering, 2nd ed., New York-London: Academic Press 1973.
Klein, G., Dombos, L., Gothoskar, B.: Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus. Int. J. Cancer 10, 44–57 (1972).
McCullough, J. L., Chabner, B. A., Bertino, J. R.: Purification and properties of carboxypeptidase G1. J. Biol. Chem. 246, 7207–7213 (1971).
Perry, R. H., Chilton, C. H., (Eds.): Chemical Engineers’ Handbook, 5th ed., New York-St. Louis-San Francisco: McGraw-Hill Book Co. 1973.
Solomons, G. L.: Materials and Methods in Fermentation, London-New York: Academic Press 1969.
Van Niel, C. B., Allen, M. B.: A note on Pseudomonas stutzen. J. Bacteriol. 64,413–422 (1952).
Zoon, K. C., Buckler, C. E., Brigden, P. J., Anfinsen, C. B.: Production of human lymphoblastoid interferon by dilution of saturation density cultures with serum-free medium. Submitted to J. Clin. Microbiol. (1977).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Langlykke, A.F. (1978). Microbial Process Translation—Laboratory to Pilot Plant at the Frederick Cancer Research Center. In: Carter, S.K., Umezawa, H., Douros, J., Sakurai, Y. (eds) Antitumor Antibiotics. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 63. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81219-4_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-81219-4_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81221-7
Online ISBN: 978-3-642-81219-4
eBook Packages: Springer Book Archive